News

Akero Therapeutics Appoints Patrick Lamy as Senior Vice President, Commercial Strategy

SOUTH SAN FRANCISCO, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational…

1 year ago

Inari Medical Announces Preliminary 2022 Revenue and 2023 Guidance

IRVINE, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a…

1 year ago

Sharps Technology Inc. to Introduce New Specialized Prefillable Syringe Systems in 2023

High-Value specialized prefillable syringe systems to accelerate revenue growth in 2023 and beyond Company to launch next generation specialty polymer-based…

1 year ago

Jasper Therapeutics Announces Development Prioritization of Briquilimab in Chronic Diseases, Including Urticaria and Lower-Risk MDS, and Stem Cell Transplant for Sickle Cell Disease and Other Rare Diseases

REDWOOD CITY, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper” or the “Company”), a biotechnology…

1 year ago

Vericel Announces Preliminary Fourth-Quarter and Full-Year 2022 Financial Results and Accelerated Launch Timeline for MACI Arthroscopic Program

Full-Year Total Revenue Expected to be Approximately $164 to $165 Million MACI Full-Year Revenue Expected to be at the High…

1 year ago

Jushi Opens 36th Dispensary Nationwide and First Retail Location in Ohio

Jushi Holdings Inc. Announces Opening of First Retail Location in Ohio Jushi Holdings Inc., a vertically integrated, multi-state cannabis operator,…

1 year ago

InMed Provides Business Update and Milestones for 2023

Complete Phase 2 clinical trial enrollment in Epidermolysis Bullosa in 1Q 2023Progress preclinical research in glaucoma in preparation for human…

1 year ago

Floré and DSM Partner to Revolutionize Probiotics Sector

MassChallenge Switzerland’s Sustainable Food Solutions Challenge facilitated the strategic pairing to help improve global gut health and wellnessSAN DIEGO and…

1 year ago

AEON Biopharma and Priveterra Acquisition Corp. Announce Additional Capital Commitment from Existing Investors for at Least $20 Million

IRVINE, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”), a clinical-stage biopharmaceutical company focused…

1 year ago

Indegene expands Europe presence with new center in Germany to enable life sciences companies be future ready

FRANKFURT, Germany and PRINCETON, N.J. and BANGALORE, India, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization…

1 year ago